Literature DB >> 7889400

Generation of normal T and B lymphocytes by c-jun deficient embryonic stem cells.

J Chen1, V Stewart, G Spyrou, F Hilberg, E F Wagner, F W Alt.   

Abstract

To determine the potential roles of c-jun in lymphocyte development, we generated somatic chimeric mice by injecting homozygous c-jun mutant embryonic stem (ES) cells into blastocysts from recombination activating gene-2 (RAG-2)-deficient mice. Chimeric mice had poor restoration of thymocytes, but contained substantial numbers of mature T and B lymphocytes in the periphery. Stimulation of c-jun-/- B cells resulted in normal levels of proliferation and immunoglobulin secretion. Likewise, stimulation of c-jun-/- T cells resulted in essentially normal levels of IL-2R alpha expression, IL-2 secretion, and proliferation. We further showed that the relatively normal activation responses of the c-jun-/- T cells probably results from the fact that other members of the Jun family contribute to the bulk of the activator protein-1 (AP-1) complexes in normal T cells and, as a result, AP-1 complexes are found at relatively normal levels in c-jun-/- T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889400     DOI: 10.1016/1074-7613(94)90010-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  11 in total

1.  c-Abl-mediated tyrosine phosphorylation of the T-bet DNA-binding domain regulates CD4+ T-cell differentiation and allergic lung inflammation.

Authors:  An Chen; Sang-Myeong Lee; Beixue Gao; Stephen Shannon; Zhou Zhu; Deyu Fang
Journal:  Mol Cell Biol       Date:  2011-06-20       Impact factor: 4.272

2.  Regulation of AP-1 and NFAT transcription factors during thymic selection of T cells.

Authors:  M Rincon; R A Flavell
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

Review 3.  The glutathione system: a new drug target in neuroimmune disorders.

Authors:  Gerwyn Morris; George Anderson; Olivia Dean; Michael Berk; Piotr Galecki; Marta Martin-Subero; Michael Maes
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

4.  The absence of the transcription activator TFE3 impairs activation of B cells in vivo.

Authors:  K Merrell; S Wells; A Henderson; J Gorman; F Alt; A Stall; K Calame
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

5.  Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT).

Authors:  A Behrens; K Sabapathy; I Graef; M Cleary; G R Crabtree; E F Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 6.  CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 7.  Targeted mutagenesis: analysis of phenotype without germ line transmission.

Authors:  A Nagy; J Rossant
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

8.  c-rel regulation of IL-2 gene expression may be mediated through activation of AP-1.

Authors:  V S Shapiro; M N Mollenauer; W C Greene; A Weiss
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

9.  Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function.

Authors:  Ye Zheng; Monika Vig; Jesse Lyons; Luk Van Parijs; Amer A Beg
Journal:  J Exp Med       Date:  2003-03-31       Impact factor: 14.307

10.  Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes.

Authors:  H Nishina; M Bachmann; A J Oliveira-dos-Santos; I Kozieradzki; K D Fischer; B Odermatt; A Wakeham; A Shahinian; H Takimoto; A Bernstein; T W Mak; J R Woodgett; P S Ohashi; J M Penninger
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.